InventisBio, Co., Ltd. () Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

InventisBio, Co., Ltd.

Why is InventisBio, Co., Ltd. ?

Poor Management Efficiency with a low ROCE of 0%

The company has reported losses and also has negative networth. This is not a good sign for the investors. Either company will have to raise fresh capital or report profits to sustain going forward

Poor long term growth as Net Sales has grown by an annual rate of 25.00% and Operating profit at -198.36% over the last 5 years

Positive results in Sep 25

OPERATING CASH FLOW(Y) Highest at CNY -76.36 MM
NET SALES(Q) At CNY 11.73 MM has Grown at 173.86%
NET PROFIT(HY) Higher at CNY -124.8 MM

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 19.84%, its profits have risen by 15%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is InventisBio, Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

InventisBio, Co., Ltd.

-44.94%

2.01

73.56%

China Shanghai Composite

16.95%

1.58

14.20%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

317.25%

EBIT Growth (5y)

-19.89%

EBIT to Interest (avg)

-276.45

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.92

Sales to Capital Employed (avg)

0.08

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

6.41

EV to EBIT

-24.42

EV to EBITDA

-25.02

EV to Capital Employed

65.53

EV to Sales

114.76

PEG Ratio

Dividend Yield

ROCE (Latest)

-268.38%

ROE (Latest)

-20.48%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bullish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

10What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -117.88% (YoY

NET SALES(Q)

Highest at CNY 42.54 MM

OPERATING PROFIT(Q)

Highest at CNY -49.77 MM

OPERATING PROFIT MARGIN(Q)

Highest at -117 %

PRE-TAX PROFIT(Q)

Highest at CNY -44.98 MM

NET PROFIT(Q)

Highest at CNY -45.09 MM

EPS(Q)

Highest at CNY -0.08

-29What is not working for the Company

NET SALES(HY)

At CNY 48.94 MM has Grown at -68.99%

NET PROFIT(HY)

At CNY -181.61 MM has Grown at -2,850.18%

INTEREST(HY)

At CNY 1.02 MM has Grown at 53.53%

ROCE(HY)

Lowest at -18.6%

DEBT-EQUITY RATIO (HY)

Highest at -90.77 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 0.46 times

Here's what is working for InventisBio, Co., Ltd.

Net Sales

At CNY 42.54 MM has Grown at 419.51%

Year on Year (YoY)

MOJO Watch

Near term sales trend is extremely positive

Net Sales (CNY MM)

Net Sales

Highest at CNY 42.54 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit

Highest at CNY -49.77 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Operating Profit Margin

Highest at -117 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at CNY -44.98 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY -45.09 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY -0.08

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Raw Material Cost

Fallen by -117.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for InventisBio, Co., Ltd.

Interest

At CNY 1.02 MM has Grown at 53.53%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debt-Equity Ratio

Highest at -90.77 % and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 0.46 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio